- Home
- LYFT vs TFX Comparison
LYFT vs TFX Comparison
Compare LYFT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYFT
- TFX
- Stock Information
- Founded
- LYFT 2007
- TFX 1943
- Country
- LYFT United States
- TFX United States
- Employees
- LYFT N/A
- TFX N/A
- Industry
- LYFT Business Services
- TFX Medical/Dental Instruments
- Sector
- LYFT Consumer Discretionary
- TFX Health Care
- Exchange
- LYFT Nasdaq
- TFX Nasdaq
- Market Cap
- LYFT 6.7B
- TFX 5.8B
- IPO Year
- LYFT 2019
- TFX N/A
- Fundamental
- Price
- LYFT $22.84
- TFX $125.68
- Analyst Decision
- LYFT Buy
- TFX Hold
- Analyst Count
- LYFT 30
- TFX 9
- Target Price
- LYFT $17.63
- TFX $141.57
- AVG Volume (30 Days)
- LYFT 24.9M
- TFX 628.8K
- Earning Date
- LYFT 11-05-2025
- TFX 10-30-2025
- Dividend Yield
- LYFT N/A
- TFX 1.08%
- EPS Growth
- LYFT N/A
- TFX N/A
- EPS
- LYFT 0.22
- TFX 4.18
- Revenue
- LYFT $6,111,324,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- LYFT $15.07
- TFX $10.39
- Revenue Next Year
- LYFT $13.76
- TFX $10.67
- P/E Ratio
- LYFT $103.34
- TFX $30.09
- Revenue Growth
- LYFT 19.94
- TFX 1.11
- 52 Week Low
- LYFT $9.66
- TFX $108.90
- 52 Week High
- LYFT $23.50
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- LYFT 81.90
- TFX 49.42
- Support Level
- LYFT $18.30
- TFX $123.53
- Resistance Level
- LYFT $20.50
- TFX $133.18
- Average True Range (ATR)
- LYFT 0.95
- TFX 3.15
- MACD
- LYFT 0.47
- TFX -0.71
- Stochastic Oscillator
- LYFT 91.68
- TFX 22.23
About LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.